Sample-to-Answer, Point-of-Care HPV DNA Test Feasible
TUESDAY, June 27, 2023 -- A sample-to-answer, point-of-care human papillomavirus (HPV) DNA test is feasible and can be performed by minimally trained personnel, according to a study published online June 21 in Science Translational Medicine.
Kathryn...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Pharmaceuticals | Science | Study